Distinct effects of IPSU and suvorexant on mouse sleep architecture

Dual orexin receptor (OXR) antagonists (DORAs) such as almorexant, SB-649868, suvorexant (MK-4305), and filorexant (MK-6096), have shown promise for the treatment of insomnias and sleep disorders. Whether antagonism of both OX(1)R and OX(2)R is necessary for sleep induction has been a matter of some...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hoyer, Daniel, Dürst, Thomas, Fendt, Markus, Jacobson, Laura H., Betschart, Claudia, Hintermann, Samuel, Behnke, Dirk, Cotesta, Simona, Laue, Grit, Ofner, Silvio, Legangneux, Eric, Gee, Christine E.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2013
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3857892/
https://ncbi.nlm.nih.gov/pubmed/24368893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2013.00235
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items